Wong will also be appointed to the board of directors as Group CEO, and Ang will continue to remain on the board of directors of AMTH.
Abel Ang, chief executive officer (CEO) of Advanced MedTech Holdings (AMTH), will retire as part of a planned leadership transition with Wong Yau Chung, previously group chief operating officer (COO), assumed the role of Group CEO-designate from July 1 and will take over as Group CEO on Oct 1.
AMTH is a wholly-owned subsidiary of state investment firm, Temasek Holdings. The company specialises in integrated medical devices for urological stone treatment.
